What is Bone Health Technologies?
Bone Health Technologies is a pioneering medical device firm that has developed Osteoboost, the first FDA-cleared wearable therapy specifically engineered to address osteopenia in postmenopausal women. By utilizing vibration therapy inspired by NASA research, the company provides a non-drug alternative that is clinically proven to mitigate bone loss in the spine and hip. The technology is designed for seamless integration into the daily lives of patients, positioning the company at the intersection of digital health and preventative medicine. As a leader in the bone health sector, the firm addresses a significant unmet need for accessible, evidence-based treatments that improve patient outcomes without the side effects associated with traditional pharmaceutical regimens.
How much funding has Bone Health Technologies raised?
Bone Health Technologies has raised a total of $7.5M across 2 funding rounds:
Unspecified
$2.5M
Other Financing Round
$5M
Unspecified (2021): $2.5M with participation from Portfolia Femtech Fund, Ambit Health Ventures, Astia, Good Growth Capital, and IT-Farm
Other Financing Round (2024): $5M led by Terumo, Berkeley Catalyst Fund, and Esplanade Ventures
Key Investors in Bone Health Technologies
Terumo
Terumo is a global medical device company originating from Japan that focuses on delivering advanced technology and reliable quality to healthcare settings worldwide.
Esplanade Ventures
Esplanade Ventures is a leading digital health venture capital firm specializing in early-stage investments and providing hands-on growth strategy for healthcare technology companies.
Good Growth Capital
Good Growth Capital is a women-owned venture capital firm that focuses on transformative science and technology investments across life sciences and medical devices.
What's next for Bone Health Technologies?
With the successful closure of this major strategic investment, Bone Health Technologies is poised to enter a phase of aggressive market penetration and operational scaling. The company is expected to leverage these resources to enhance its manufacturing capabilities, broaden its clinical research initiatives, and strengthen its distribution channels within the global healthcare market. By focusing on the intersection of wearable technology and chronic condition management, the firm is well-positioned to capture a larger share of the preventative health market. Future strategic efforts will likely prioritize the integration of Osteoboost into standard clinical care pathways, further solidifying its role as a cornerstone of modern bone health management.
See full Bone Health Technologies company page
